Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Oxford BioDynamics ( (GB:OBD) ) has provided an announcement.
Oxford BioDynamics PLC announced it has successfully raised £7 million through a placing and direct subscriptions, issuing 1.4 billion new ordinary shares. This fundraising provides additional working capital to support the commercial development of its EpiSwitch® product line. The company plans to focus on partnerships and collaborations to enhance sales and shareholder value, potentially restructuring to maximize its cash runway.
More about Oxford BioDynamics
Oxford BioDynamics PLC is a precision clinical diagnostics company specializing in developing specific and sensitive tests using its EpiSwitch® 3D genomics platform. The company focuses on advancing the practice of medicine through innovative genomic technologies.
YTD Price Performance: -40.0%
Average Trading Volume: 4,651,142
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £2.91M
Find detailed analytics on OBD stock on TipRanks’ Stock Analysis page.
